Clinical Trial Update: A Randomized Controlled Trial Comparing Chondro-Gide® to Microfracture Alone for Treatment of Knee Cartilage Defects. [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing Chondro-Gide collagen membrane to microfracture alone for knee cartilage defects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cartilage Injury
• Osteochondritis Dissecans

Drugs mentioned

• Chondro-Gide
• Microfracture (surgical microfracture)

Snippet

Sponsor: Geistlich Pharma AG | Conditions: Cartilage Injury, Osteochondritis Dissecans | Phase 3 | Status: COMPLETED